Swapna Reddy
Dermatology · Gilroy, CANPI 1467754200
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $84,175 of the $101,555 with a category attached, or 82.9%. Sun Pharmaceutical Industries Inc. accounts for 92.0% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2020 at $29,985 and has fallen 99.3% since, to $203 in 2025. Among dermatology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 278 payments — averaging $365.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$93K
- Novartis$5K
- AbbVie$878
- Johnson & Johnson$759
- Galderma Laboratories, L.p.$316
- UCB, Inc.$227
- plus $1K from 15 others
What the payments were for
- Consulting fees$3,8454%
- Speaking & faculty fees$84,17583%
- Travel & lodging$7,7628%
- Food & beverage$5,5735%
- Education$1990%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 93 | $93,401 |
| Novartis | 52 | $4,845 |
| AbbVie | 41 | $878 |
| Johnson & Johnson | 31 | $759 |
| Galderma Laboratories, L.p. | 4 | $316 |
| UCB, Inc. | 6 | $227 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $206 |
| Pfizer | 15 | $183 |
| Sanofi | 6 | $126 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $109 |
| Regeneron Healthcare Solutions, Inc. | 5 | $96 |
| Lilly USA, LLC | 4 | $89 |
| Incyte Corporation | 3 | $80 |
| Endo Pharmaceuticals Inc. | 1 | $68 |
| Arcutis Biotherapeutics, Inc. | 3 | $45 |
| Prugen, Inc. Pharmaceuticals | 3 | $41 |
| Dermavant Sciences, Inc. | 1 | $22 |
| Bristol Myers Squibb | 1 | $18 |
| Journey Medical Corporation | 1 | $18 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Amgen | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$101,555 in reported general payments places this provider in the 95th percentile of 1,875 dermatology providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 74 | $2,599 |
| Metronidazole | 20 | $1,011 |
| Triamcinolone Acetonide | 67 | $890 |
| Fluorouracil | 14 | $794 |
| Ketoconazole | 18 | $222 |
| Hydrocortisone | 34 | $215 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Gilroy
- Paul YamauchiSanta Monica$2.9M
- Jennifer SoungSanta Ana$2.8M
- Robert GreenbergLivermore$2.6M
- Neal BhatiaSan Diego$2.5M
- April ArmstrongLos Angeles$2.3M
- Jeffrey CrowleyBakersfield$2.1M
- Jashin WuCorona$2M
- Raja SivamaniSacramento$1.9M
- Tien NguyenFountain Valley$1.2M
- Tina BhutaniSan Francisco$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.